NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Phylo

Phylo

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://phylo.bio/

Last Round

Seed

Feb 3, 2026

Est. Valuation

$53.21M

Total Funding Raised

$13.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Phylo is a biotechnology and artificial intelligence company that provides an integrated biology environment with agentic AI to help scientists plan, author, and execute complex research tasks.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Data Integration, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

biotechnology softwarelaboratory data managementgenomic researchdrug discoverybioinformatics platformAI research assistantbiotech AIvertical SaaSdata integrationhigh-performance computingHPCprotein designsequence alignmentvariant callinglab informatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phylo Comparables

Compare Phylo with similar companies based on industry and business-model similarity.

Phylo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Phylo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 3, 2026

Key People

Founding team and executive leadership

Kexin Huang

Co-founder and CEO

Founding Team

Phylo Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    Integrating GeneCards' human gene knowledge base into the Biomni Lab platform.

  • Feb 3, 2026

    $14M raised in Seed round.

Phylo Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Phylo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Phylo's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range14
Year Founded2025
Last FundingFeb 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.